BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 32928266)

  • 1. Hsa_circ_0001944 promotes the growth and metastasis in bladder cancer cells by acting as a competitive endogenous RNA for miR-548.
    Jin M; Lu S; Wu Y; Yang C; Shi C; Wang Y; Huang G
    J Exp Clin Cancer Res; 2020 Sep; 39(1):186. PubMed ID: 32928266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput sequencing identified circular RNA circUBE2K mediating RhoA associated bladder cancer phenotype via regulation of miR-516b-5p/ARHGAP5 axis.
    Yang C; Mou Z; Wu S; Ou Y; Zhang Z; Chen X; Dai X; Xu C; Mao S; Jiang H
    Cell Death Dis; 2021 Jul; 12(8):719. PubMed ID: 34285193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
    Jin J; Liu H; Jin M; Li W; Xu H; Wei F
    Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA hsa_circ_0001785 inhibits the proliferation, migration and invasion of breast cancer cells in vitro and in vivo by sponging miR-942 to upregulate SOCS3.
    Li Z; Zheng J; Lin W; Weng J; Hong W; Zou J; Zhang T; Ye C; Chen Y
    Cell Cycle; 2020 Nov; 19(21):2811-2825. PubMed ID: 33054543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA hsa_circ_0004872 inhibits gastric cancer progression via the miR-224/Smad4/ADAR1 successive regulatory circuit.
    Ma C; Wang X; Yang F; Zang Y; Liu J; Wang X; Xu X; Li W; Jia J; Liu Z
    Mol Cancer; 2020 Nov; 19(1):157. PubMed ID: 33172486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ_0008532 promotes bladder cancer progression by regulation of the miR-155-5p/miR-330-5p/MTGR1 axis.
    Chen L; Yang X; Zhao J; Xiong M; Almaraihah R; Chen Z; Hou T
    J Exp Clin Cancer Res; 2020 May; 39(1):94. PubMed ID: 32460831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA hsa_circ_0014130 Inhibits Apoptosis in Non-Small Cell Lung Cancer by Sponging miR-136-5p and Upregulating BCL2.
    Geng Y; Bao Y; Zhang W; Deng L; Su D; Zheng H
    Mol Cancer Res; 2020 May; 18(5):748-756. PubMed ID: 32060230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA hsa_circ_0076248 promotes oncogenesis of glioma by sponging miR-181a to modulate SIRT1 expression.
    Lei B; Huang Y; Zhou Z; Zhao Y; Thapa AJ; Li W; Cai W; Deng Y
    J Cell Biochem; 2019 Apr; 120(4):6698-6708. PubMed ID: 30506951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy-associated circular RNA hsa_circ_0007813 modulates human bladder cancer progression via hsa-miR-361-3p/IGF2R regulation.
    Zhang Z; Mou Z; Xu C; Wu S; Dai X; Chen X; Ou Y; Chen Y; Yang C; Jiang H
    Cell Death Dis; 2021 Aug; 12(8):778. PubMed ID: 34365465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated circRNA hsa_circ_0071036 promotes tumourigenesis of pancreatic cancer by sponging miR-489 and predicts unfavorable characteristics and prognosis.
    Han X; Fang Y; Chen P; Xu Y; Zhou W; Rong Y; Li JA; Chen W; Lou W
    Cell Cycle; 2021 Feb; 20(4):369-382. PubMed ID: 33507122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing circular RNA VANGL1 inhibits progression of bladder cancer by regulating miR-1184/IGFBP2 axis.
    Yang D; Qian H; Fang Z; Xu A; Zhao S; Liu B; Li D
    Cancer Med; 2020 Jan; 9(2):700-710. PubMed ID: 31758655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA hsa_circ_0001829 promotes gastric cancer progression through miR-155-5p/SMAD2 axis.
    Niu Q; Dong Z; Liang M; Luo Y; Lin H; Lin M; Zhong X; Yao W; Weng J; Zhou X
    J Exp Clin Cancer Res; 2020 Dec; 39(1):280. PubMed ID: 33308284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circ-UBR1 facilitates proliferation, metastasis, and inhibits apoptosis in breast cancer by regulating the miR-1299/CCND1 axis.
    Zhang L; Sun D; Zhang J; Tian Y
    Life Sci; 2021 Feb; 266():118829. PubMed ID: 33259864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA hsa_circ_0000751 serves as a microRNA-488 sponge to suppress gastric cancer progression via ubiquinol-cytochrome c reductase core protein 2 regulation.
    Wang D; Su F; Feng M
    Bioengineered; 2021 Dec; 12(1):8793-8808. PubMed ID: 34565283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsa_circRNA_102229 facilitates the progression of triple-negative breast cancer via regulating the miR-152-3p/PFTK1 pathway.
    Du C; Zhang J; Zhang L; Zhang Y; Wang Y; Li J
    J Gene Med; 2021 Sep; 23(9):e3365. PubMed ID: 34031947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of hsa_circ_0007874 suppresses the progression of ovarian cancer by regulating the miR-760/SOCS3 pathway.
    Li L; Yu P; Zhang P; Wu H; Chen Q; Li S; Wang Y
    Cancer Med; 2020 Apr; 9(7):2491-2499. PubMed ID: 32023009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA hsa_circ_0054537 sponges miR-130a-3p to promote the progression of renal cell carcinoma through regulating cMet pathway.
    Li R; Luo S; Zhang D
    Gene; 2020 Sep; 754():144811. PubMed ID: 32464246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
    Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
    J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients.
    Shen C; Wu Z; Wang Y; Gao S; Da L; Xie L; Qie Y; Tian D; Hu H
    Cancer Med; 2020 Jun; 9(11):3885-3903. PubMed ID: 32250047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive circular RNA profiling reveals the regulatory role of the hsa_circ_0137606/miR‑1231 pathway in bladder cancer progression.
    Li W; Li Y; Sun Z; Zhou J; Cao Y; Ma W; Xie K; Yan X
    Int J Mol Med; 2019 Nov; 44(5):1719-1728. PubMed ID: 31545480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.